At a glance
- Originator Pharmacia Corporation
- Class Antibacterials; Penems; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 16 Apr 2003 Pharmacia has been acquired by Pfizer
- 30 May 2001 Profile reviewed but no significant changes made
- 16 Apr 1996 No-Development-Reported for Bacterial infections in Italy (PO)